,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,179,1,1,,503147,10208,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
1,256,1,1,,93582,10208,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
2,330,1,1,,93582,10208,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
3,421,1,3,,17389107,10208,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
4,426,1,2,,17389107,10208,Inactive,,,,,Cell Viability - Jurkat,Confirmatory,,
5,427,1,1,,17389107,10208,Inactive,,,,,Cell Viability - Hek293,Confirmatory,,
6,433,1,1,,17389107,10208,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
7,434,1,2,,17389107,10208,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
8,435,1,2,,17389107,10208,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
9,445,3,1,,17389107,10208,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
10,485,1,8,,22405477,10208,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
11,530,1,1,,17389107,10208,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
12,540,1,1,,17389107,10208,Inactive,,,,,Cell Viability - N2a,Confirmatory,,
13,541,1,1,,17389107,10208,Inactive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
14,542,1,1,,17389107,10208,Inactive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
15,543,1,1,,17389107,10208,Inactive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
16,544,2,1,,17389107,10208,Inactive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
17,545,1,1,,17389107,10208,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
18,546,1,1,,17389107,10208,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
19,584,1,3,,17389107,10208,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
20,585,1,4,,17389107,10208,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
21,595,1,3,,17389107,10208,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
22,596,1,2,,17389107,10208,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
23,603,1,2,,17389107,10208,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
24,605,1,2,,17389107,10208,Inconclusive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
25,608,1,6,,11537514,10208,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
26,631,1,4,,22405477,10208,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
27,631,1,4,,22405477,10208,Inactive,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
28,654,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
29,655,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
30,656,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
31,657,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
32,658,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
33,659,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
34,660,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
35,661,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
36,662,1,1,,17389107,10208,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
37,663,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
38,664,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
39,665,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
40,666,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
41,667,1,1,,17389107,10208,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
42,731,1,5,,22405477,10208,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
43,731,1,5,,22405477,10208,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
44,757,1,4,,22405477,10208,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype,Screening,,
45,758,1,4,,22405477,10208,Inactive,164058.0,404007.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype,Screening,,
46,759,1,4,,22405477,10208,Inactive,190938.0,3265.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype,Screening,,
47,760,1,4,,22405477,10208,Inactive,46577642.0,404009.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype,Screening,,
48,761,1,4,,22405477,10208,Inactive,56202836.0,,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype,Screening,,
49,764,1,4,,22405477,10208,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant,Screening,,
50,775,1,3,,22405477,10208,Inactive,,,,,Screen for Chemicals that Extend Yeast Lifespan,Screening,,
51,781,1,1,,22405477,10208,Inactive,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
52,782,1,2,,22405477,10208,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
53,782,1,2,,22405477,10208,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
54,793,1,2,,22405477,10208,Inactive,4505447.0,4887.0,,,Primary cell based high-throughput screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2),Screening,,
55,797,1,1,,22405477,10208,Inactive,115529463.0,5587.0,,,Fluorescence polarization assay for PKD inhibitors,Screening,,
56,798,2,12,,22405477,10208,Inactive,180352.0,,,,Factor XIa 1536 HTS,Screening,,
57,799,1,5,,22405477,10208,Inactive,134142337.0,4363.0,,,Identification of Molecular Probes that Activate MRP-1,Screening,,
58,800,2,11,,22405477,10208,Inactive,317373446.0,2161.0,,,Factor XIIa 1536 HTS,Screening,,
59,803,1,4,,22405477,10208,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2),Screening,,
60,804,1,3,,22405477,10208,Inactive,,,,,Screen for Chemicals that Shorten Yeast Lifespan,Screening,,
61,817,1,1,,22405477,10208,Inactive,1360328.0,,,,Identification and characterization of compounds for addressing human bone marrow failure,Other,,
62,818,1,2,,22405477,10208,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression,Screening,,
63,827,1,2,,22405477,10208,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor,Screening,,
64,828,1,5,,22405477,10208,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify antagonists of Galanin Receptor 2 (GALR2),Screening,,
65,841,1,1,,22405477,10208,Inactive,,,,,Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library),Screening,,
66,861,1,1,,22405477,10208,Inactive,55662034.0,,,,Primary cell-based high-throughput screening assay for inhibitors of TLR4-MyD88 binding,Screening,,
67,862,1,2,,22405477,10208,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 inhibition,Screening,,
68,868,1,3,,22405477,10208,Inactive,,,,,Screen for Chemicals that Inhibit the RAM Network,Screening,,
69,871,1,2,,22405477,10208,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 activation,Screening,,
70,873,1,13,,22405477,10208,Inactive,6912644.0,25818.0,,,Kallikrein 5 1536 HTS,Screening,,
71,875,1,2,,17389107,10208,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
72,878,1,2,,22405477,10208,Inactive,,,,,NIH Compound Library Profiling: Compound and DTT Dependent Redox Cycling H2O2 Generation.,Screening,,
73,880,2,1,,17389107,10208,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
74,880,2,1,,17389107,10208,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
75,880,2,1,,22405477,10208,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
76,880,2,1,,22405477,10208,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
77,880,2,1,,26747395,10208,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
78,880,2,1,,26747395,10208,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
79,880,2,1,,50105639,10208,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
80,880,2,1,,50105639,10208,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
81,881,2,2,,17389107,10208,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
82,884,1,2,,17389107,10208,Inconclusive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
83,885,1,2,,17389107,10208,Inactive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
84,886,1,2,,17389107,10208,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
85,886,1,2,,17389107,10208,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
86,887,1,2,,17389107,10208,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
87,889,1,3,,17389107,10208,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
88,892,1,2,,17389107,10208,Inactive,159162802.0,,39.8107,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
89,893,1,2,,17389107,10208,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
90,893,1,2,,17389107,10208,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
91,894,2,1,,17389107,10208,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
92,894,2,1,,22405477,10208,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
93,894,2,1,,26747395,10208,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
94,894,2,1,,50105639,10208,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
95,898,1,1,,22405477,10208,Inactive,28373018.0,1239205.0,,,YopH  HTS,Screening,,
96,900,1,3,,17389107,10208,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
97,901,1,2,,17389107,10208,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
98,902,1,2,,17389107,10208,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
99,910,1,2,,17389107,10208,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
100,912,1,2,,17389107,10208,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
101,920,1,2,,22405477,10208,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 inhibition,Screening,,
102,921,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-001,Confirmatory,,
103,923,1,2,,17389107,10208,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
104,924,1,2,,17389107,10208,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
105,925,1,2,,17389107,10208,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
106,926,1,2,,17389107,10208,Inconclusive,38016895.0,7253.0,15.8489,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
107,927,1,3,,17389107,10208,Inactive,188528692.0,9099.0,25.1189,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
108,930,1,2,,17389107,10208,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
109,932,1,4,,22405477,10208,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 activation,Screening,,
110,938,1,2,,17389107,10208,Inactive,38016895.0,7253.0,15.8489,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
111,940,1,2,,22405477,10208,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
112,940,1,2,,26613293,10208,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
113,946,1,2,,17389107,10208,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
114,947,1,2,,17389107,10208,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
115,948,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
116,950,1,1,,22405477,10208,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
117,951,1,1,,22405477,10208,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
118,952,1,1,,22405477,10208,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
119,955,1,2,,17389107,10208,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
120,960,1,2,,17389107,10208,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
121,961,1,2,,17389107,10208,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
122,962,1,2,,17389107,10208,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
123,963,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
124,964,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
125,965,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
126,966,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-004,Confirmatory,,
127,967,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
128,968,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-009,Confirmatory,,
129,969,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-011,Confirmatory,,
130,970,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-013,Confirmatory,,
131,971,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-015,Confirmatory,,
132,972,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-017,Confirmatory,,
133,973,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-019,Confirmatory,,
134,974,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-021,Confirmatory,,
135,975,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-023,Confirmatory,,
136,976,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
137,977,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
138,978,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-006,Confirmatory,,
139,979,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-007,Confirmatory,,
140,980,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-008,Confirmatory,,
141,981,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-010,Confirmatory,,
142,982,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-012,Confirmatory,,
143,983,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-014,Confirmatory,,
144,984,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-016,Confirmatory,,
145,985,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-018,Confirmatory,,
146,986,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-020,Confirmatory,,
147,987,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-022,Confirmatory,,
148,988,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-024,Confirmatory,,
149,989,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP2-026,Confirmatory,,
150,993,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
151,994,1,2,,17389107,10208,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
152,995,1,2,,17389107,10208,Inconclusive,66932916.0,5594.0,3.1623,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
153,1001,2,2,,22405477,10208,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
154,1006,1,6,,22405477,10208,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
155,1007,1,1,,22405477,10208,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
156,1008,1,2,,22405477,10208,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
157,1009,1,2,,22405477,10208,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
158,1012,1,4,,22405477,10208,Inactive,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
159,1016,1,4,,22405477,10208,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
160,1018,2,5,,22405477,10208,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
161,1019,1,4,,22405477,10208,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
162,1020,1,5,,22405477,10208,Inactive,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
163,1021,1,1,,22405477,10208,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
164,1022,1,1,,22405477,10208,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
165,1027,1,3,,22405477,10208,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
166,1030,2,1,,17389107,10208,Active,30582681.0,216.0,12.5893,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
167,1030,2,1,,22405477,10208,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
168,1030,2,1,,26747395,10208,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
169,1030,2,1,,50105639,10208,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
170,1032,1,2,,22405477,10208,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
171,1032,1,2,,22405477,10208,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
172,1033,2,2,,11537514,10208,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
173,1040,1,2,,22405477,10208,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
174,1046,1,6,,22405477,10208,Inactive,339641.0,2147.0,,,Thrombin 1536 HTS,Screening,,
175,1048,1,1,,22405477,10208,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
176,1048,1,1,,22405477,10208,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
177,1049,1,1,,22405477,10208,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
178,1049,1,1,,22405477,10208,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
179,1051,1,1,,22405477,10208,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
180,1051,1,1,,22405477,10208,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
181,1063,1,1,,22405477,10208,Inactive,,,,,Leishmania major promastigote HTS,Screening,,
182,1066,1,2,,22405477,10208,Inactive,9937384.0,,,,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Primary Screen,Screening,,
183,1085,1,1,,22405477,10208,Inactive,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
184,1135,1,3,,22405477,10208,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
185,1136,1,3,,22405477,10208,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
186,1203,1,3,,22405477,10208,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
187,1209,2,2,,22405477,10208,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
188,1214,1,4,,22405477,10208,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
189,1216,1,5,,22405477,10208,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
190,1217,1,4,,22405477,10208,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
191,1220,2,2,,22405477,10208,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
192,1222,1,6,,22405477,10208,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
193,1229,1,3,,22405477,10208,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
194,1236,1,1,,22405477,10208,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
195,1239,1,3,,22405477,10208,Inactive,34577122.0,4790.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
196,1239,1,3,,22405477,10208,Inactive,223468676.0,5970.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
197,1242,1,1,,22405477,10208,Inactive,11094021.0,,,,C. albicans biofilm killing---Mixture HTS,Screening,,
198,1246,1,2,,22405477,10208,Inactive,56417702.0,,,,Primary HTS assay for chemical inhibitors of TNF alpha stimulated E-Selectin expression,Screening,,
199,1251,1,1,,22405477,10208,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
200,1273,1,1,,22405477,10208,Inactive,59036749.0,3630.0,,,Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells,Screening,,
201,1274,1,2,,22405477,10208,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
202,1276,1,1,,22405477,10208,Inactive,257380.0,351.0,,,Primary screen for compounds that activate Alzheimer's amyloid precursor,Screening,,
203,1285,1,1,,22405477,10208,Inactive,257380.0,351.0,,,Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation,Screening,,
204,1296,1,1,,22405477,10208,Inactive,59036749.0,3630.0,,,Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells,Screening,,
205,1304,1,2,,22405477,10208,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
206,1321,1,2,,22405477,10208,Inactive,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
207,1325,1,2,,22405477,10208,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
208,1326,1,4,,22405477,10208,Inactive,42741659.0,5243.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen",Screening,,
209,1359,1,4,,22405477,10208,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
210,1362,1,2,,22405477,10208,Inactive,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
211,1376,1,2,,22405477,10208,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
212,1377,1,1,,22405477,10208,Inactive,,,,,HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells.,Screening,,
213,1379,1,2,,22405477,10208,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
214,1379,1,2,,26747395,10208,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
215,1379,1,2,,50105639,10208,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
216,1381,1,1,,22405477,10208,Inactive,,,,,HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules.,Screening,,
217,1385,2,2,,22405477,10208,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
218,1415,1,2,,22405477,10208,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
219,1415,1,2,,22405477,10208,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
220,1416,1,2,,22405477,10208,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
221,1422,1,1,,22405477,10208,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
222,1422,1,1,,26613293,10208,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
223,1423,1,2,,22405477,10208,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
224,1423,1,2,,22405477,10208,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
225,1424,1,1,,22405477,10208,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
226,1430,1,1,,22405477,10208,Inactive,70832125.0,3663016.0,,,HTS assay for inhibitors of Trypanosoma brucei hexokinase 1,Screening,,
227,1434,2,3,,22405477,10208,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
228,1434,2,3,,22405477,10208,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
229,1439,1,1,,22405477,10208,Inactive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
230,1439,1,1,,22405477,10208,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
231,1440,1,1,,22405477,10208,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
232,1440,1,1,,22405477,10208,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
233,1441,1,1,,22405477,10208,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
234,1441,1,1,,22405477,10208,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
235,1443,1,3,,22405477,10208,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
236,1445,1,1,,22405477,10208,Inactive,124512980.0,813945.0,,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
237,1446,1,3,,22405477,10208,Inactive,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
238,1448,1,3,,22405477,10208,Inactive,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
239,1452,1,1,,17389107,10208,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
240,1452,1,1,,22405477,10208,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
241,1454,1,1,,22405477,10208,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
242,1454,1,1,,26747395,10208,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
243,1454,1,1,,50105639,10208,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
244,1456,1,1,,22405477,10208,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
245,1457,1,1,,17389107,10208,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
246,1457,1,1,,22405477,10208,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
247,1457,1,1,,26747395,10208,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
248,1457,1,1,,50105639,10208,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
249,1458,1,1,,17389107,10208,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
250,1458,1,1,,22405477,10208,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
251,1458,1,1,,26747395,10208,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
252,1460,1,3,,22405477,10208,Inconclusive,92096784.0,4137.0,3.1623,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
253,1460,1,3,,26747395,10208,Inconclusive,92096784.0,4137.0,2.8184,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
254,1460,1,3,,50105639,10208,Inconclusive,92096784.0,4137.0,2.2387,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
255,1461,1,2,,22405477,10208,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
256,1463,1,1,,22405477,10208,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
257,1463,1,1,,26747395,10208,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
258,1463,1,1,,50105639,10208,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
259,1465,1,1,,22405477,10208,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
260,1466,1,2,,22405477,10208,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
261,1467,1,3,,22405477,10208,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
262,1467,1,3,,26747395,10208,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
263,1467,1,3,,50105639,10208,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
264,1468,1,1,,22405477,10208,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
265,1468,1,1,,26747395,10208,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
266,1468,1,1,,50105639,10208,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
267,1469,1,1,,17389107,10208,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
268,1469,1,1,,22405477,10208,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
269,1469,1,1,,26747395,10208,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
270,1469,1,1,,50105639,10208,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
271,1471,2,1,,17389107,10208,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
272,1471,2,1,,50105639,10208,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
273,1476,2,1,,17389107,10208,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
274,1476,2,1,,22405477,10208,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
275,1476,2,1,,26747395,10208,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
276,1476,2,1,,50105639,10208,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
277,1477,1,1,,17389107,10208,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
278,1477,1,1,,22405477,10208,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
279,1477,1,1,,50105639,10208,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
280,1478,2,1,,17389107,10208,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
281,1478,2,1,,22405477,10208,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
282,1478,2,1,,26747395,10208,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
283,1478,2,1,,50105639,10208,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
284,1479,1,2,,17389107,10208,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
285,1479,1,2,,22405477,10208,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
286,1479,1,2,,26747395,10208,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
287,1479,1,2,,50105639,10208,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
288,1481,1,2,,22405477,10208,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
289,1486,1,3,,22405477,10208,Inactive,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
290,1487,1,1,,22405477,10208,Inconclusive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
291,1487,1,1,,26747395,10208,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
292,1490,2,1,,22405477,10208,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
293,1490,2,1,,26747395,10208,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
294,1490,2,1,,50105639,10208,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
295,1496,1,4,,22405477,10208,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
296,1496,1,4,,22405477,10208,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
297,1509,1,2,,22405477,10208,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
298,1510,1,3,,22405477,10208,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
299,1515,1,2,,22405477,10208,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
300,1519,1,3,,26747395,10208,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
301,1519,1,3,,50105639,10208,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
302,1527,1,3,,22405477,10208,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
303,1529,1,1,,22405477,10208,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
304,1530,1,1,,22405477,10208,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
305,1531,1,1,,22405477,10208,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
306,1532,1,1,,22405477,10208,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
307,1549,1,2,,11537514,10208,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
308,1552,1,3,,11537514,10208,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
309,1556,1,4,,22405477,10208,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
310,1565,2,2,,22405477,10208,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
311,1566,2,3,,22405477,10208,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
312,1578,3,2,,22405477,10208,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
313,1619,1,2,,22405477,10208,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
314,1621,1,2,,22405477,10208,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
315,1625,2,2,,22405477,10208,Inactive,,,,EC50,HCS for Compounds that Up-Regulate Insulin Promoter Activity in MIN6 Cells,Confirmatory,,
316,1626,1,2,,22405477,10208,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
317,1628,2,2,,22405477,10208,Inactive,,,,IC50,HCS for Compounds that Down-Regulate Insulin Promoter Activity in MIN6 Cells,Confirmatory,,
318,1631,3,1,,22405477,10208,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
319,1634,3,1,,22405477,10208,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
320,1637,1,2,,11537514,10208,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
321,1648,1,2,,11537514,10208,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
322,1654,2,2,,22405477,10208,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
323,1656,2,2,,22405477,10208,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
324,1688,1,1,,22405477,10208,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
325,1700,1,2,,22405477,10208,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
326,1706,1,2,,22405477,10208,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
327,1721,1,2,,22405477,10208,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
328,1722,1,2,,22405477,10208,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
329,1766,1,1,,22405477,10208,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
330,1766,1,1,,22405477,10208,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
331,1766,1,1,,26747395,10208,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
332,1766,1,1,,26747395,10208,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
333,1766,1,1,,50105639,10208,Inconclusive,18860839.0,4221.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
334,1766,1,1,,50105639,10208,Inconclusive,56550039.0,4297.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
335,1768,1,1,,22405477,10208,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
336,1768,1,1,,22405477,10208,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
337,1768,1,1,,26747395,10208,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
338,1768,1,1,,26747395,10208,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
339,1768,1,1,,50105639,10208,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
340,1768,1,1,,50105639,10208,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
341,1775,1,2,,22405477,10208,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
342,1776,1,2,,22405477,10208,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
343,1777,3,2,,22405477,10208,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
344,1778,3,3,,22405477,10208,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
345,1779,2,2,,22405477,10208,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
346,1789,1,2,,22405477,10208,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
347,1800,1,2,,22405477,10208,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
348,1817,2,2,,22405477,10208,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
349,1822,1,3,,22405477,10208,Inactive,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
350,1825,1,1,,22405477,10208,Inactive,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
351,1845,1,2,,22405477,10208,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
352,1861,2,1,,22405477,10208,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
353,1863,2,1,,22405477,10208,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
354,1865,1,1,,22405477,10208,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
355,1865,1,1,,26747395,10208,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
356,1865,1,1,,50105639,10208,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
357,1903,2,3,,22405477,10208,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
358,1918,1,2,,22405477,10208,Inactive,223460826.0,3758.0,,,High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen,Screening,,
359,1948,1,1,,17389107,10208,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
360,1948,1,1,,26747395,10208,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
361,1948,1,1,,50105639,10208,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
362,1956,1,1,,22405477,10208,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
363,1961,2,2,,22405477,10208,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
364,1984,1,3,,22405477,10208,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
365,1986,1,2,,22405477,10208,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
366,2006,3,2,,22405477,10208,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
367,2006,3,2,,22405477,10208,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
368,2006,3,2,,22405477,10208,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
369,2012,3,2,,22405477,10208,Inconclusive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
370,2013,2,2,,22405477,10208,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
371,2014,3,2,,22405477,10208,Inconclusive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
372,2058,3,2,,22405477,10208,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
373,2071,2,2,,22405477,10208,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
374,2073,2,3,,22405477,10208,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
375,2073,2,3,,22405477,10208,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
376,2100,1,1,,22405477,10208,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
377,2101,1,1,,17389107,10208,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
378,2101,1,1,,22405477,10208,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
379,2101,1,1,,26747395,10208,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
380,2101,1,1,,50105639,10208,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
381,2107,1,1,,17389107,10208,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
382,2107,1,1,,22405477,10208,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
383,2107,1,1,,26747395,10208,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
384,2107,1,1,,50105639,10208,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
385,2112,1,1,,17389107,10208,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
386,2112,1,1,,22405477,10208,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
387,2112,1,1,,26747395,10208,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
388,2112,1,1,,50105639,10208,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
389,2120,1,1,,17389107,10208,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
390,2147,1,1,,22405477,10208,Inconclusive,221046486.0,,25.1189,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
391,2147,1,1,,26747395,10208,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
392,2147,1,1,,50105639,10208,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
393,2205,1,1,,22405477,10208,Inactive,29788785.0,203068.0,,,HCS assay for microtubule stabilizers,Screening,,
394,2240,1,1,,85789285,10208,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
395,2241,1,1,,85789285,10208,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
396,2242,1,1,,22405477,10208,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
397,2275,1,1,,85789285,10208,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
398,2288,1,1,,22405477,10208,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
399,2289,1,1,,22405477,10208,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
400,2313,1,1,,85789285,10208,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
401,2314,1,2,,22405477,10208,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
402,2314,1,2,,22405477,10208,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
403,2315,1,2,,22405477,10208,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
404,2315,1,2,,22405477,10208,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
405,2322,1,1,,85789285,10208,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
406,2326,1,1,,22405477,10208,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
407,2330,1,1,,85789285,10208,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
408,2417,1,1,,22405477,10208,Inactive,4506243.0,5725.0,,,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment,Screening,,
409,2451,1,2,,22405477,10208,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
410,2451,1,2,,26747395,10208,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
411,2451,1,2,,50105639,10208,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
412,2472,1,2,,22405477,10208,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
413,2472,1,2,,26747395,10208,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
414,2472,1,2,,50105639,10208,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
415,2517,2,1,,17389107,10208,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
416,2517,2,1,,22405477,10208,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
417,2517,2,1,,26747395,10208,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
418,2517,2,1,,50105639,10208,Active,6980812.0,,31.6228,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
419,2528,1,2,,22405477,10208,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
420,2528,1,2,,26747395,10208,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
421,2528,1,2,,50105639,10208,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
422,2546,1,1,,17389107,10208,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
423,2546,1,1,,22405477,10208,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
424,2546,1,1,,26747395,10208,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
425,2546,1,1,,50105639,10208,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
426,2549,1,1,,17389107,10208,Active,282403581.0,,7.0795,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
427,2549,1,1,,22405477,10208,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
428,2549,1,1,,26747395,10208,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
429,2549,1,1,,50105639,10208,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
430,2551,1,1,,17389107,10208,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
431,2551,1,1,,22405477,10208,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
432,2551,1,1,,26747395,10208,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
433,2551,1,1,,50105639,10208,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
434,2662,2,1,,22405477,10208,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
435,2675,1,1,,22405477,10208,Inactive,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
436,2676,1,2,,22405477,10208,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
437,2685,1,1,,22405477,10208,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
438,2732,1,1,,22405477,10208,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
439,19840,3,4,,174520441,10208,Unspecified,,,,,Partition coefficient of compound in octanol and water by Fragmental method of Leo/Hansch,Other,12639543.0,
440,37282,5,1,,174520441,10208,Inconclusive,,,,,Inhibitory activity against rat alpha-glucosidase; mild activity observed,Other,15203173.0,
441,37426,4,7,,174520441,10208,Inconclusive,,,,,Inhibitory activity against yeast alpha-glucosidase; mild activity observed,Other,15203173.0,
442,48225,3,7,,174520441,10208,Unspecified,,,,,Inhibitory activity against Cathepsin G (CatG) at 28 uM concentration,Other,1578486.0,
443,52613,6,4,,174520441,10208,Inactive,,,,,Inhibitory activity against Chymotrypsinogen at 28 uM concentration; NI = no inhibition,Other,1578486.0,
444,66482,9,2,,174520441,10208,Active,,,18.0,IC50,Compound was tested for the enzyme inhibitory activity against Human Leukocyte Elastase (HLE) at 28 uM concentration,Confirmatory,1578486.0,
445,67310,3,7,,174520441,10208,Unspecified,,,,,Inhibitory activity against Human Leukocyte Elastase (HLE) at 28 uM concentration,Other,1578486.0,
446,67640,6,4,,174520441,10208,Inactive,,,,,Inhibitory activity against Porcine Pancreatic Elastase (PPE) at 28 uM concentration; NI = no inhibition,Other,1578486.0,
447,98690,8,1,,174520441,10208,Unspecified,,,393.0,ID50,In vitro inhibition of L1210 mouse leukemia cell proliferation.,Confirmatory,3339601.0,
448,102409,4,8,,174520441,10208,Unspecified,,,,,Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 1 uM,Other,11459643.0,
449,102410,4,8,,174520441,10208,Unspecified,,,,,Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 10 uM,Other,11459643.0,
450,102411,4,8,,174520441,10208,Unspecified,,,,,Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 3 uM,Other,11459643.0,
451,132501,6,2,,174520441,10208,Unspecified,,,100.0,IC50,Inhibitory activity against nitric oxide production in LPS-activated mouse peritoneal macrophages,Confirmatory,10714491.0,
452,134177,3,3,,174520441,10208,Unspecified,,,,,Compound (at 100 uM) was tested for inhibition against nitric oxide production in LPS-activated mouse peritoneal macrophages,Other,10714491.0,
453,260049,3,6,,174520441,10208,Inactive,,,,,Inhibitory activity on PDGF-induced ERK phosphorylation in NIH3T3 cells at 20 uM,Other,16275083.0,
454,260051,5,4,,174520441,10208,Unspecified,,,,,Antiproliferative activity against human epidermal carcinoma A431 cell line at 20 uM by MTT method,Other,16275083.0,
455,260052,5,4,,174520441,10208,Unspecified,,,,,Antiproliferative activity against prostate cancer PC3 cell line at 20 uM by MTT method,Other,16275083.0,
456,260053,3,3,,174520441,10208,Unspecified,,,,,Antifungal activity against Fusarium oxysporum at 0.5 mg/ml,Other,16275083.0,
457,260054,3,3,,174520441,10208,Unspecified,,,,,Antifungal activity against Gibberella zeae at 0.5 mg/ml,Other,16275083.0,
458,260055,3,3,,174520441,10208,Unspecified,,,,,Antifungal activity against Phytopthora infestans at 0.5 mg/ml,Other,16275083.0,
459,285171,6,2,,174520441,10208,Unspecified,,,,,Activity against planktonic Streptococcus mutans LMG 14558,Other,17220400.0,
460,285172,3,3,,174520441,10208,Unspecified,,,,,Effect on Streptococcus mutans LMG 14558 assessed as inhibition of biofilm formation in modified Robbin's device at 5 ug/ml relative to BHIS control,Other,17220400.0,
461,289106,6,2,,174520441,10208,Unspecified,,,20.0,EC50,Cytotoxicity against human KB cells,Confirmatory,17552563.0,
462,327061,6,3,,174520441,10208,Unspecified,,,,,Cytotoxicity against BALB/c mouse 3T3 cells,Other,18163590.0,
463,327062,6,2,,174520441,10208,Unspecified,,,,,Cytotoxicity against human H460 cells,Other,18163590.0,
464,327063,6,3,,174520441,10208,Unspecified,,,,,Cytotoxicity against human ME180 cells,Other,18163590.0,
465,327064,6,2,,174520441,10208,Unspecified,,,,,Cytotoxicity against human DU145 cells,Other,18163590.0,
466,327065,6,2,,174520441,10208,Unspecified,,,,,Cytotoxicity against human MCF7 cells,Other,18163590.0,
467,327066,6,2,,174520441,10208,Unspecified,,,,,Cytotoxicity against human M14 cells,Other,18163590.0,
468,327067,6,2,,174520441,10208,Unspecified,,,,,Cytotoxicity against human HT29 cells,Other,18163590.0,
469,327068,6,2,,174520441,10208,Unspecified,,,,,Cytotoxicity against human PC3 cells,Other,18163590.0,
470,327069,6,2,,174520441,10208,Unspecified,,,,,Cytotoxicity against human K562 cells,Other,18163590.0,
471,327070,6,2,,174520441,10208,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells,Other,18163590.0,
472,327073,3,3,,174520441,10208,Inactive,,,,,Antimicrobial activity against Mycobacterium tuberculosis H37Rv at 25 ug/ml,Other,18163590.0,
473,335922,6,1,,174520441,10208,Unspecified,,,,,Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of arachidonic acid-stimulated platelet aggregation pretreated 2 mins before arachidonic acid challenge,Other,2213033.0,
474,335923,6,1,,174520441,10208,Unspecified,,,,,Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of ADP-stimulated platelet aggregation pretreated 2 mins before ADP challenge,Other,2213033.0,
475,335924,6,1,,174520441,10208,Unspecified,,,,,Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of collagen-stimulated platelet aggregation pretreated 2 mins before collagen challenge,Other,2213033.0,
476,336287,5,1,,174520441,10208,Unspecified,,,,,Cytotoxicity against human PLC/PRF/5 cells,Other,,
477,336288,5,1,,174520441,10208,Unspecified,,,,,Cytotoxicity against human KB cells,Other,,
478,338266,3,4,,174520441,10208,Inactive,,,,,Inhibition of Ca2+ ATPase activity in human red blood cells at 1600 uM by spectrophotometry,Other,7714535.0,
479,339131,3,4,,174520441,10208,Unspecified,,,,,Inhibition of ADP-induced platelet aggregation in rabbit platelet-rich plasma at 50 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
480,339132,3,4,,174520441,10208,Unspecified,,,,,Inhibition of arachidonic acid-induced platelet aggregation in rabbit platelet-rich plasma at 50 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
481,339133,3,4,,174520441,10208,Unspecified,,,,,Inhibition of collagen-induced platelet aggregation in rabbit platelet-rich plasma at 50 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
482,339134,3,4,,174520441,10208,Unspecified,,,,,Inhibition of platelet activity factor-induced platelet aggregation in rabbit platelet-rich plasma at 50 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
483,341228,3,3,,174520441,10208,Inactive,,,,,Reduction of cell viability in rabbit HIG82 cells at 2 uM followed by illumination at 2.5 W/cm'2 cold light for 40 seconds by XTT assay,Other,18605693.0,
484,341232,3,4,,174520441,10208,Inactive,,,,,Reduction of cell viability in mouse J774A.1 cells at 2 uM followed by illumination at 2.5 W/cm'2 cold light for 40 seconds by XTT assay,Other,18605693.0,
485,341234,3,3,,174520441,10208,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus DSM1104 on exposure to 2.5 W/cm'2 cold light for 40 secs at 1 to 100 uM,Other,18605693.0,
486,341235,3,3,,174520441,10208,Unspecified,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus DSM11729 on exposure to 2.5 W/cm'2 cold light for 40 secs at 1 to 100 uM,Other,18605693.0,
487,341236,3,3,,174520441,10208,Inactive,,,,,Antimicrobial activity against methicillin-resistant Pseudomonas aeruginosa DSM1117 on exposure to 2.5 W/cm'2 cold light for 40 secs at 1 to 100 uM,Other,18605693.0,
488,343962,3,5,,174520441,10208,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells,Other,18556196.0,
489,356320,6,3,,174520441,10208,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity,Other,12932135.0,
490,357642,6,2,,174520441,10208,Inactive,,,,IC50,Cytotoxicity against human KB cells,Confirmatory,11575949.0,
491,360618,6,3,,174520441,10208,Unspecified,,,100.0,IC50,Inhibition of human Calu1 cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
492,360626,6,2,,174520441,10208,Unspecified,,,100.0,IC50,Inhibition of human HeLa cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
493,360633,6,2,,174520441,10208,Unspecified,,,100.0,IC50,Inhibition of human K562 cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
494,360640,6,2,,174520441,10208,Unspecified,,,100.0,IC50,Inhibition of human Raji cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
495,360647,6,2,,174520441,10208,Unspecified,,,100.0,IC50,Inhibition of african green monkey Vero cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
496,360654,6,2,,174520441,10208,Unspecified,,,100.0,IC50,Inhibition of human WISH cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
497,363328,6,2,,174520441,10208,Active,,,47.4,IC50,Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay,Confirmatory,17949858.0,
498,363329,6,2,,174520441,10208,Unspecified,,,64.4,IC50,Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay,Confirmatory,17949858.0,
499,375433,9,5,,174520441,10208,Unspecified,21263835.0,64805.0,10.0,Ki,Displacement of [3H]PSB0413 from human platelet P2Y12 receptor,Confirmatory,19463000.0,
500,375434,4,7,,174520441,10208,Unspecified,21263835.0,64805.0,,,Displacement of [3H]PSB0413 from human platelet P2Y12 receptor at 10 uM,Other,19463000.0,
501,377974,3,4,,174520441,10208,Inactive,,,,,Antituberculosis activity against Mycobacterium tuberculosis at 12.5 ug/mL,Other,9917291.0,
502,398698,3,5,,174520441,10208,Unspecified,,,,,Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced oxygen consumption up to 0.3 mM relative to control,Other,7494143.0,
503,398699,3,5,,174520441,10208,Unspecified,,,,,Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced malondialdehyde formation up to 0.3 mM relative to control,Other,7494143.0,
504,399960,5,1,,174520441,10208,Unspecified,,,,,Cytotoxicity against human Lu1 cells,Other,15043409.0,
505,399961,5,1,,174520441,10208,Unspecified,,,,,Cytotoxicity against human LNCAP cells,Other,15043409.0,
506,399962,5,1,,174520441,10208,Unspecified,,,,,Cytotoxicity against human MCF7 cells,Other,15043409.0,
507,399963,5,1,,174520441,10208,Unspecified,,,,,Cytotoxicity against HUVEC,Other,15043409.0,
508,434959,1,1,,85789285,10208,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
509,449739,1,2,,22405477,10208,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
510,449768,1,1,,22405477,10208,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
511,463075,1,1,,22405477,10208,Inactive,,,,,HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells.,Screening,,
512,463115,1,1,,22405477,10208,Inactive,119622516.0,5045.0,,,High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center.,Screening,,
513,463187,1,1,,22405477,10208,Inactive,,,,,384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC,Screening,,
514,463193,1,1,,22405477,10208,Inactive,31563518.0,84557.0,,,High-content cell-based screening for modulators of autophagy,Screening,,
515,463254,1,1,,22405477,10208,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
516,485281,1,1,,22405477,10208,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
517,485281,1,1,,26747395,10208,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
518,485290,1,1,,17389107,10208,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
519,485290,1,1,,22405477,10208,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
520,485290,1,1,,26747395,10208,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
521,485290,1,1,,50105639,10208,Inconclusive,20150581.0,,19.9526,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
522,485294,1,1,,22405477,10208,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
523,485297,1,1,,22405477,10208,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
524,485298,1,1,,22405477,10208,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
525,485313,1,2,,22405477,10208,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
526,485314,1,1,,22405477,10208,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
527,485341,1,1,,22405477,10208,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
528,485344,1,1,,22405477,10208,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
529,485347,1,2,,22405477,10208,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
530,485349,1,1,,22405477,10208,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
531,485353,2,1,,22405477,10208,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
532,485358,1,1,,22405477,10208,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
533,485360,1,1,,22405477,10208,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
534,485364,1,1,,22405477,10208,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
535,485367,1,2,,22405477,10208,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
536,488837,1,1,,22405477,10208,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
537,492947,1,1,,22405477,10208,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
538,493014,1,1,,22405477,10208,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
539,493056,1,1,,22405477,10208,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
540,493084,1,1,,22405477,10208,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
541,504327,1,1,,22405477,10208,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
542,504327,1,1,,26747395,10208,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
543,504327,1,1,,50105639,10208,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
544,504332,1,1,,22405477,10208,Inconclusive,168985070.0,,79.4328,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
545,504333,1,1,,22405477,10208,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
546,504466,1,1,,22405477,10208,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
547,504467,1,1,,22405477,10208,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
548,504651,1,1,,22405477,10208,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
549,504652,1,1,,22405477,10208,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
550,504660,1,1,,22405477,10208,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
551,504706,1,1,,22405477,10208,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
552,504810,1,2,,22405477,10208,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
553,504812,1,2,,22405477,10208,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
554,504832,1,1,,22405477,10208,Inactive,,,8.2753,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
555,504834,1,1,,22405477,10208,Inactive,,,3.2944,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
556,504842,1,1,,22405477,10208,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
557,504845,1,1,,50105639,10208,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
558,504847,1,1,,26747395,10208,Active,63054845.0,7421.0,39.8107,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
559,504847,1,1,,50105639,10208,Active,63054845.0,7421.0,14.1254,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
560,504865,1,1,,26747395,10208,Inconclusive,118600387.0,7398.0,63.0957,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
561,504865,1,1,,50105639,10208,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
562,540256,1,2,,22405477,10208,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
563,540275,1,1,,22405477,10208,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
564,540276,1,2,,17389107,10208,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
565,540276,1,2,,22405477,10208,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
566,540276,1,2,,26747395,10208,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
567,540276,1,2,,50105639,10208,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
568,540276,1,2,,50105640,10208,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
569,540277,1,1,,22405477,10208,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
570,551520,11,2,,174520441,10208,Unspecified,357529586.0,58819.0,194.0,IC50,Inhibition of rat liver cytosolic TrxR1 by spectrophotometry,Confirmatory,21106380.0,
571,551521,11,2,,174520441,10208,Unspecified,172045556.0,50551.0,181.0,IC50,Inhibition of rat liver mitochondrial TrxR2 by spectrophotometry,Confirmatory,21106380.0,
572,588342,1,1,,22405477,10208,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
573,588379,1,2,,50105639,10208,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
574,588513,1,1,,17389107,10208,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
575,588514,1,1,,17389107,10208,Inconclusive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
576,588515,1,1,,17389107,10208,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
577,588516,1,1,,17389107,10208,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
578,588526,1,1,,17389107,10208,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
579,588527,1,1,,17389107,10208,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
580,588532,1,1,,17389107,10208,Inconclusive,311348376.0,2908.0,25.1189,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
581,588533,1,1,,17389107,10208,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
582,588534,1,1,,17389107,10208,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
583,588535,1,1,,17389107,10208,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
584,588536,1,1,,17389107,10208,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
585,588537,1,1,,17389107,10208,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
586,588541,1,1,,17389107,10208,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
587,588543,1,1,,17389107,10208,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
588,588544,1,1,,17389107,10208,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
589,588545,1,1,,17389107,10208,Inconclusive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
590,588546,1,1,,17389107,10208,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
591,588547,1,1,,17389107,10208,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
592,588579,1,1,,26747395,10208,Inconclusive,7705344.0,51426.0,25.1189,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
593,588579,1,1,,50105639,10208,Inconclusive,7705344.0,51426.0,12.5893,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
594,588834,2,1,,17389107,10208,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
595,602332,1,1,,26747395,10208,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
596,602332,1,1,,50105639,10208,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
597,624101,1,2,,85789285,10208,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
598,624137,1,1,,85789285,10208,Inactive,881546.0,3400.0,,,SMM ID4 Measured in Biochemical System Using Small Molecule MicroArray - 2128-01_Other_SinglePoint_HTS_Activity,Screening,,
599,624156,1,1,,85789285,10208,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
600,624260,1,1,,85789285,10208,Inactive,109633019.0,7468.0,,,NSD2 Inhibitors Measured in Biochemical System Using Plate Reader - 2115-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
601,624263,1,1,,26747395,10208,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
602,624263,1,1,,26747395,10208,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
603,624296,1,1,,22405477,10208,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
604,624297,1,1,,22405477,10208,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
605,624377,1,1,,22405477,10208,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
606,624416,1,1,,22405477,10208,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
607,624466,1,3,,22405477,10208,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
608,624467,1,1,,22405477,10208,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
609,624606,1,9,,174520441,10208,Unspecified,136729.0,54658.0,,,Specific activity of expressed human recombinant UGT1A1,Other,10836148.0,
610,624609,1,9,,174520441,10208,Unspecified,29840832.0,54578.0,,,Specific activity of expressed human recombinant UGT1A6,Other,10836148.0,
611,624612,1,9,,174520441,10208,Unspecified,29839451.0,54600.0,,,Specific activity of expressed human recombinant UGT1A9,Other,10836148.0,
612,651548,1,1,,85789285,10208,Inactive,21361095.0,2146.0,,,EZH2/PRC2 methyltransferase inhibitors Measured in Biochemical System Using Plate Reader - 2125-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
613,651572,1,2,,22405477,10208,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
614,651602,1,1,,22405477,10208,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
615,651602,1,1,,22405477,10208,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
616,651602,1,1,,22405477,10208,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
617,651610,2,1,,22405477,10208,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
618,651631,4,1,,144209697,10208,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
619,651632,4,1,,144209697,10208,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
620,651633,4,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
621,651634,4,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
622,651640,1,1,,22405477,10208,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
623,651658,1,1,,22405477,10208,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
624,651661,2,1,,22405477,10208,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
625,651704,2,1,,22405477,10208,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
626,651710,1,1,,22405477,10208,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
627,651711,2,1,,22405477,10208,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
628,651718,1,2,,22405477,10208,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
629,651719,1,2,,22405477,10208,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
630,651741,1,1,,17389107,10208,Active,20149576.0,4780.0,26.6032,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
631,651743,1,1,,17389107,10208,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
632,651749,1,1,,17389107,10208,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
633,651751,1,1,,17389107,10208,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
634,651754,1,1,,17389107,10208,Inconclusive,,,3.3491,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
635,651755,1,1,,17389107,10208,Inconclusive,,,5.9557,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
636,651757,1,1,,17389107,10208,Inactive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
637,651758,1,1,,17389107,10208,Inactive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
638,651777,1,1,,17389107,10208,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
639,651778,1,1,,17389107,10208,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
640,651800,1,1,,22405477,10208,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
641,651802,1,1,,17389107,10208,Inactive,49066040.0,6097.0,6.6824,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
642,651820,1,1,,22405477,10208,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
643,651821,2,4,,22405477,10208,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
644,651838,1,1,,17389107,10208,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
645,651838,1,1,1.0,17389107,10208,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
646,651838,1,1,2.0,17389107,10208,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
647,651838,1,1,3.0,17389107,10208,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
648,651838,1,1,4.0,17389107,10208,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
649,651838,1,1,5.0,17389107,10208,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
650,651838,1,1,6.0,17389107,10208,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
651,651838,1,1,7.0,17389107,10208,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
652,651838,1,1,8.0,17389107,10208,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
653,651957,1,1,,22405477,10208,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
654,651958,1,1,,22405477,10208,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
655,652010,1,1,,22405477,10208,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
656,652017,1,1,,22405477,10208,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
657,652039,1,1,,22405477,10208,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
658,652067,1,4,,22405477,10208,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
659,652126,1,3,,22405477,10208,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
660,652154,1,1,,22405477,10208,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
661,652162,2,1,,22405477,10208,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
662,652163,1,1,,22405477,10208,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
663,652197,1,1,,22405477,10208,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
664,652257,1,1,,22405477,10208,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
665,686940,1,1,,22405477,10208,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
666,686964,1,1,,22405477,10208,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
667,686978,1,1,,26747395,10208,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
668,686978,1,1,,50105639,10208,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
669,686979,1,1,,26747395,10208,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
670,686979,1,1,,50105639,10208,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
671,686996,1,1,,22405477,10208,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
672,687014,1,1,,22405477,10208,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
673,687016,1,1,,22405477,10208,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
674,720508,1,1,,22405477,10208,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
675,720509,1,1,,22405477,10208,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
676,720511,1,1,,22405477,10208,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
677,720516,2,1,,144209697,10208,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
678,720532,1,1,,26747395,10208,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
679,720532,1,1,,50105639,10208,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
680,720533,1,1,,26747395,10208,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
681,720533,1,1,,50105639,10208,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
682,720543,1,1,,22405477,10208,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
683,720552,2,1,,144209697,10208,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
684,720579,2,1,,26747395,10208,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
685,720580,1,1,,26747395,10208,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
686,720582,1,1,,22405477,10208,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
687,720596,1,1,,22405477,10208,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
688,720634,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
689,720635,2,1,,144209697,10208,Active,,,11.9074,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
690,720636,1,1,,17389107,10208,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
691,720637,2,1,,144209697,10208,Active,,,11.2413,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
692,720648,1,1,,22405477,10208,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
693,720652,1,1,,17389107,10208,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
694,720653,1,1,,17389107,10208,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
695,720659,1,1,,17389107,10208,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
696,720674,2,2,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
697,720675,2,2,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
698,720678,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
699,720679,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
700,720680,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
701,720681,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
702,720682,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
703,720683,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
704,720684,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
705,720685,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
706,720686,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
707,720687,2,2,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
708,720691,4,1,,144209697,10208,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
709,720692,3,1,,144209697,10208,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
710,720693,3,1,,144209697,10208,Inconclusive,,,26.8916,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
711,720700,1,4,,22405477,10208,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
712,720702,1,1,,22405477,10208,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
713,720704,1,4,,22405477,10208,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
714,720719,2,1,,144209697,10208,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
715,720725,2,1,,144209697,10208,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
716,743012,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
717,743014,3,1,,144209697,10208,Inconclusive,,,33.5596,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
718,743015,3,1,,144209697,10208,Active,,,26.6573,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
719,743033,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
720,743035,2,1,,144209697,10208,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
721,743036,2,1,,144209697,10208,Inconclusive,124375976.0,367.0,26.8916,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
722,743040,3,1,,144209697,10208,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
723,743041,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
724,743042,3,1,,144209697,10208,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
725,743053,2,1,,144209697,10208,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
726,743054,2,1,,144209697,10208,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
727,743063,2,1,,144209697,10208,Inconclusive,124375976.0,367.0,23.9671,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
728,743064,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
729,743065,3,1,,144209697,10208,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
730,743066,3,1,,144209697,10208,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
731,743067,2,1,,144209697,10208,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
732,743069,2,1,,144209697,10208,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
733,743074,2,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
734,743075,2,1,,144209697,10208,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
735,743077,2,1,,144209697,10208,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
736,743078,2,1,,144209697,10208,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
737,743079,3,1,,144209697,10208,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
738,743080,3,1,,144209697,10208,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
739,743081,3,1,,144209697,10208,Inconclusive,,,33.5596,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
740,743083,3,1,,144209697,10208,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
741,743084,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
742,743085,3,1,,144209697,10208,Active,51095037.0,196.0,26.6573,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
743,743086,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
744,743091,2,1,,144209697,10208,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
745,743093,1,2,,22405477,10208,Inactive,,,,,Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of viability of late stage Plasmodium falciparum gametocytes,Screening,,
746,743094,3,1,,144209697,10208,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
747,743122,2,1,,144209697,10208,Active,51095037.0,196.0,20.3775,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
748,743126,1,1,,22405477,10208,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
749,743139,2,1,,144209697,10208,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
750,743140,2,1,,144209697,10208,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
751,743191,3,1,,144209697,10208,Inconclusive,216409692.0,5468.0,16.9674,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
752,743194,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
753,743199,2,1,,144209697,10208,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
754,743202,4,1,,144209697,10208,Active,20149576.0,4780.0,10.6125,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
755,743203,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
756,743209,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
757,743210,4,1,,144209697,10208,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
758,743211,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
759,743212,3,1,,144209697,10208,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
760,743213,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
761,743215,3,1,,144209697,10208,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
762,743217,3,1,,144209697,10208,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
763,743218,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
764,743219,3,1,,144209697,10208,Active,20149576.0,4780.0,12.8573,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
765,743220,3,1,,144209697,10208,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
766,743221,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
767,743222,3,1,,144209697,10208,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
768,743223,3,1,,144209697,10208,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
769,743224,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
770,743225,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
771,743226,2,1,,144209697,10208,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
772,743227,2,1,,144209697,10208,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
773,743228,3,1,,144209697,10208,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
774,743238,1,1,,22405477,10208,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
775,743239,2,1,,144209697,10208,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
776,743240,2,1,,144209697,10208,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
777,743241,2,1,,144209697,10208,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
778,743242,2,1,,144209697,10208,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
779,743247,1,2,,22405477,10208,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
780,743269,1,1,,22405477,10208,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
781,743269,1,1,,22405477,10208,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
782,743288,1,1,,17389107,10208,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
783,743292,1,1,,17389107,10208,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
784,743344,1,1,,174006595,10208,Inactive,,,0.0019,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
785,743345,1,1,,174006595,10208,Inactive,,,0.0017,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
786,743346,1,1,,174006595,10208,Inactive,,,0.0006,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
787,743347,1,1,,174006595,10208,Inactive,,,0.4214,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
788,743397,1,1,,22405477,10208,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
789,743398,1,1,,22405477,10208,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
790,755271,1,2,,174520441,10208,Unspecified,,,,,Cytotoxicity against rat HBZY-1 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay,Other,23683594.0,
791,755272,1,1,,174520441,10208,Active,,,,,Antidiabetic nephropathic activity in rat HBZY-1 cells assessed as inhibition of high concentration glucose-induced fibronectin production at 10 uM treated 1 hr before glucose challenge measured after 24 hrs by ELISA,Other,23683594.0,
792,755273,1,1,,174520441,10208,Active,,,,,Antidiabetic nephropathic activity in rat HBZY-1 cells assessed as inhibition of high concentration glucose-induced collagen-4 production at 10 uM treated 1 hr before glucose challenge measured after 24 hrs by ELISA,Other,23683594.0,
793,755276,1,1,,174520441,10208,Active,,,,,Antidiabetic nephropathic activity in rat HBZY-1 cells assessed as inhibition of high concentration glucose-induced IL-6 production at 10 uM treated 1 hr before glucose challenge measured after 24 hrs by ELISA,Other,23683594.0,
794,977599,1,1,,174520441,10208,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
795,977602,1,2,,174520441,10208,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
796,1053197,1,1,,22405477,10208,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
797,1062995,1,2,,174520441,10208,Unspecified,,,58.0,IC50,Antiplasmodial activity against chloroquine-resistant ring stage Plasmodium falciparum Dd2 after 72 hrs by SYBR Green 1-based fluorescence assay,Confirmatory,24326280.0,
798,1062996,1,2,,174520441,10208,Unspecified,,,60.0,IC50,Cytotoxicity against human A2780 cells,Confirmatory,24326280.0,
799,1072523,2,1,,174520441,10208,Unspecified,,,,IC50,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production,Confirmatory,24549242.0,
800,1072528,2,1,,174520441,10208,Unspecified,,,,IC50,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion,Confirmatory,24549242.0,
801,1072529,2,1,,174520441,10208,Unspecified,,,,IC50,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion,Confirmatory,24549242.0,
802,1080758,1,1,,174520441,10208,Unspecified,,,,,Antifungal activity against Botryotinia fuckeliana assessed as growth inhibition at 500 ug/mL after 4 days,Other,19650641.0,
803,1080760,1,1,,174520441,10208,Unspecified,,,,,Antifungal activity against Rhizoctonia solani assessed as growth inhibition at 500 ug/mL after 2 days,Other,19650641.0,
804,1080765,1,1,,174520441,10208,Unspecified,,,,,Antibacterial activity against Bacillus cereus using 50 uL of compound solution from 500 ug/mL stock solution after 24 hr by agar disk diffusion method,Other,19650641.0,
805,1080766,1,1,,174520441,10208,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus using 50 uL of compound solution from 500 ug/mL stock solution after 24 hr by agar disk diffusion method,Other,19650641.0,
806,1080767,1,1,,174520441,10208,Unspecified,,,,,Antibacterial activity against Escherichia coli using 50 uL of compound solution from 500 ug/mL stock solution after 24 hr by agar disk diffusion method,Other,19650641.0,
807,1080768,1,1,,174520441,10208,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa using 50 uL of compound solution from 500 ug/mL stock solution after 24 hr by agar disk diffusion method,Other,19650641.0,
808,1082590,1,1,,174520441,10208,Unspecified,,,,,Antifungal activity against Blumeria graminis f. sp. hordei assessed as control of barley powdery mildew treated 1 day before inoculation,Other,21992072.0,
809,1083211,3,1,,174520441,10208,Inactive,,,,,Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition in King's B full medium measured at pH 7.2 after overnight incubation by suspension culture assay,Other,23163769.0,
810,1091700,1,1,,174520441,10208,Inactive,,,,,Antifungal activity against Leptosphaeria maculans isolate UWA P11 assessed as growth inhibition at 0.01 to 200 ug/plug,Other,19413806.0,
811,1091701,1,1,,174520441,10208,Inactive,,,,,Antifungal activity against Botryotinia fuckeliana assessed as growth inhibition at 0.01 to 200 ug/plug,Other,19413806.0,
812,1091702,1,1,,174520441,10208,Inactive,,,,,Antifungal activity against Phytophthora cinnamomi assessed as growth inhibition at 0.01 to 200 ug/plug,Other,19413806.0,
813,1097036,1,2,,174520441,10208,Unspecified,,,,,Antiamoebic activity against Entamoeba histolytica,Other,,
814,1098732,1,2,,174520441,10208,Unspecified,,,,,Antifeedant activity against Spodoptera litura in Ricinus communis leaves assessed as mean leaf area fed by dual choice leaf disc bioassay,Other,,
815,1098733,1,2,,174520441,10208,Unspecified,,,,,Antifeedant activity against Spodoptera litura in Ricinus communis leaves assessed as mean leaf area fed at 1 ug/cm'2 by dual choice leaf disc bioassay (Rvb = 53 +/- 2.44 to 53.6 +/- 2.61 cm'2),Other,,
816,1098734,1,2,,174520441,10208,Unspecified,,,,,Antifeedant activity against Spodoptera litura in Ricinus communis leaves assessed as mean leaf area fed at 5 ug/cm'2 by dual choice leaf disc bioassay (Rvb = 52.6 +/- 1.34 to 55.6 +/- 3.71 cm'2),Other,,
817,1098735,1,2,,174520441,10208,Unspecified,,,,,Antifeedant activity against Spodoptera litura in Ricinus communis leaves assessed as mean leaf area fed at 10 ug/cm'2 by dual choice leaf disc bioassay (Rvb = 52.8 +/- 2.50 to 53.6 +/- 4.76 cm'2),Other,,
818,1098736,1,2,,174520441,10208,Unspecified,,,,,Antifeedant activity against Henosepilachna vigintioctopunctata in Solanum nigrum leaves assessed as mean leaf area fed by dual choice leaf disk bioassay,Other,,
819,1098737,1,2,,174520441,10208,Unspecified,,,,,Antifeedant activity against Henosepilachna vigintioctopunctata in Solanum nigrum leaves assessed as mean leaf area fed at 1 ug/cm'2 by dual choice leaf disk bioassay (Rvb = 0.75 +/- 0.06 to 0.92 +/- 0.05 cm'2),Other,,
820,1098738,1,2,,174520441,10208,Unspecified,,,,,Antifeedant activity against Henosepilachna vigintioctopunctata in Solanum nigrum leaves assessed as mean leaf area fed at 5 ug/cm'2 by dual choice leaf disk bioassay (Rvb = 0.74 +/- 0.02 to 0.91 +/- 0.01 cm'2),Other,,
821,1098739,1,2,,174520441,10208,Unspecified,,,,,Antifeedant activity against Henosepilachna vigintioctopunctata in Solanum nigrum leaves assessed as mean leaf area fed at 10 ug/cm'2 by dual choice leaf disk bioassay (Rvb = 0.78 +/- 0.04 to 0.99 +/- 0.17 cm'2),Other,,
822,1102423,1,1,,174520441,10208,Inactive,,,,,Antifungal activity against Botryotinia fuckeliana assessed as inhibition of conidia germination at 1 to 10 ug/mL after 5 hr by light adverse phase microscopic analysis,Other,12903946.0,
823,1102424,3,1,,174520441,10208,Unspecified,,,,,Antifungal activity against Verticillium dahliae assessed as mycelial growth inhibition after 4 to 8 days,Other,12903946.0,
824,1102425,3,1,,174520441,10208,Unspecified,,,,,Antifungal activity against Sclerotinia sclerotiorum assessed as mycelial growth inhibition after 4 to 8 days,Other,12903946.0,
825,1102426,3,1,,174520441,10208,Unspecified,,,,,Antifungal activity against Sclerotinia minor assessed as mycelial growth inhibition after 4 to 8 days,Other,12903946.0,
826,1102427,3,1,,174520441,10208,Unspecified,,,,,Antifungal activity against Botryotinia fuckeliana assessed as mycelial growth inhibition after 4 to 8 days,Other,12903946.0,
827,1141754,1,3,,174520441,10208,Unspecified,754286265.0,443551.0,,,Inhibition of ovine COX1 using arachidonic acid as substrate at 30 uM preincubated for 10 mins before substrate addition measured after 5 mins by EIA,Other,24763362.0,
828,1141755,1,3,,174520441,10208,Unspecified,3914304.0,443460.0,,,Inhibition of ovine COX2 using arachidonic acid as substrate at 30 uM preincubated for 10 mins before substrate addition measured after 5 mins by EIA,Other,24763362.0,
829,1141756,1,3,,174520441,10208,Active,754286265.0,443551.0,46.21,IC50,Inhibition of ovine COX1 using arachidonic acid as substrate preincubated for 10 mins before substrate addition measured after 5 mins by EIA,Confirmatory,24763362.0,
830,1141757,1,3,,174520441,10208,Active,3914304.0,443460.0,36.12,IC50,Inhibition of ovine COX2 using arachidonic acid as substrate preincubated for 10 mins before substrate addition measured after 5 mins by EIA,Confirmatory,24763362.0,
831,1141758,1,1,,174520441,10208,Unspecified,,,,,"Selectivity index, ratio of IC50 for ovine COX1 to IC50 for ovine COX2",Other,24763362.0,
832,1159509,1,1,,144209697,10208,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
833,1159515,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
834,1159516,1,1,,144209697,10208,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
835,1159517,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
836,1159518,1,1,,144209697,10208,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
837,1159519,1,1,,144209697,10208,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
838,1159520,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
839,1159521,1,1,,144209697,10208,Inactive,15928672.0,19885.0,11.9074,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
840,1159523,1,1,,144209697,10208,Inconclusive,15928672.0,19885.0,11.9074,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
841,1159524,1,1,,26747395,10208,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
842,1159525,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
843,1159526,1,1,,144209697,10208,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
844,1159527,1,1,,144209697,10208,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
845,1159528,1,1,,144209697,10208,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
846,1159529,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
847,1159531,1,1,,144209697,10208,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
848,1159550,3,1,,252401365,10208,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
849,1159551,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
850,1159552,1,1,,144209697,10208,Inactive,325495463.0,5914.0,26.6573,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
851,1159553,2,1,,144209697,10208,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
852,1159555,1,1,,144209697,10208,Inconclusive,325495463.0,5914.0,8.429789999999999,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
853,1159580,2,1,,268736046,10208,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
854,1159607,2,1,,312996089,10208,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
855,1224824,1,1,,174006595,10208,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
856,1224825,1,1,,174006595,10208,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
857,1224834,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
858,1224835,1,1,,144209697,10208,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
859,1224836,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
860,1224837,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
861,1224838,1,1,,144209697,10208,Inactive,66775687.0,9970.0,16.8196,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
862,1224839,1,1,,144209697,10208,Active,66775687.0,9970.0,26.6573,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
863,1224840,3,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
864,1224841,3,1,,144209697,10208,Active,325495545.0,2101.0,1.1907,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
865,1224842,3,1,,144209697,10208,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
866,1224843,1,1,,144209697,10208,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
867,1224844,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
868,1224845,1,1,,144209697,10208,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
869,1224846,1,1,,144209697,10208,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
870,1224847,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
871,1224848,3,1,,144209697,10208,Inconclusive,325495545.0,2101.0,11.9074,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
872,1224849,3,1,,144209697,10208,Inactive,325495545.0,2101.0,11.9074,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
873,1224857,2,1,,174006595,10208,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
874,1224859,2,1,,174006595,10208,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
875,1224867,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
876,1224868,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
877,1224869,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
878,1224870,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
879,1224871,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
880,1224872,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
881,1224873,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
882,1224874,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
883,1224875,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
884,1224876,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
885,1224877,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
886,1224878,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
887,1224879,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
888,1224880,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
889,1224881,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
890,1224882,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
891,1224883,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
892,1224884,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
893,1224885,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
894,1224886,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
895,1224887,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
896,1224888,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
897,1224889,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
898,1224890,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
899,1224892,1,1,,144209697,10208,Active,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
900,1224893,1,1,,144209697,10208,Inconclusive,66775687.0,9970.0,21.1747,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
901,1224894,1,1,,144209697,10208,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
902,1224895,1,1,,144209697,10208,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
903,1224896,1,1,,144209697,10208,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
904,1256630,1,1,,174520441,10208,Unspecified,67476665.0,2053.0,,,Inhibition of sEH (unknown origin) assessed as 6-methoxy-2-naphthaldehyde formation at 50 uM by fluorometry assay using 40 uM cyano-(6-methoxy-naphthalen-2-yl)-methyl ester as substrate,Other,26483136.0,
905,1259241,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
906,1259242,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
907,1259243,1,1,,144209697,10208,Active,124375976.0,367.0,9.4584,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
908,1259244,1,1,,144209697,10208,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
909,1259247,1,1,,144209697,10208,Active,124375976.0,367.0,8.75958,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
910,1259248,1,1,,144209697,10208,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
911,1259252,1,1,,174006595,10208,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
912,1259253,1,1,,174006595,10208,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
913,1259255,1,1,,174006595,10208,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
914,1259256,1,1,,174006595,10208,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
915,1259310,1,1,,333473025,10208,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
916,1259318,1,1,,22405477,10208,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
917,1259364,1,1,,144209697,10208,Active,1013403374.0,9734.0,13.3603,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
918,1259365,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
919,1259366,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
920,1259367,1,1,,144209697,10208,Inconclusive,,,26.6573,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
921,1259368,1,1,,144209697,10208,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
922,1259369,1,1,,144209697,10208,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
923,1259377,1,1,,144209697,10208,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
924,1259378,1,1,,144209697,10208,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
925,1259379,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
926,1259380,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
927,1259381,1,1,,144209697,10208,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
928,1259382,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
929,1259383,1,1,,144209697,10208,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
930,1259384,1,1,,144209697,10208,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
931,1259385,1,1,,144209697,10208,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
932,1259386,1,1,,144209697,10208,Inconclusive,,,23.7584,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
933,1259387,1,1,,144209697,10208,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
934,1259388,1,1,,144209697,10208,Active,1013403374.0,9734.0,15.577,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
935,1259389,1,1,,124636202,10208,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
936,1259390,1,1,,144209697,10208,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
937,1259391,1,1,,144209697,10208,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
938,1259392,1,1,,144209697,10208,Inconclusive,109731339.0,2737.0,23.7584,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
939,1259393,1,1,,144209697,10208,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
940,1259394,1,1,,144209697,10208,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
941,1259395,1,1,,144209697,10208,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
942,1259396,1,1,,144209697,10208,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
943,1259401,1,1,,144209697,10208,Active,325495545.0,2101.0,1.19074,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
944,1259402,1,1,,144209697,10208,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
945,1259403,1,1,,144209697,10208,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
946,1259404,1,1,,144209697,10208,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
947,1259407,1,1,,363901475,10208,Inactive,,,,,CCRIS mutagenicity studies,Other,,
948,1259415,1,1,,22405477,10208,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
949,1259416,1,2,,340086057,10208,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
950,1259416,1,2,,375177931,10208,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
951,1259421,1,1,,340086057,10208,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
952,1259421,1,1,,375177931,10208,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
953,1259423,1,2,,354993827,10208,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
